Results 151 to 160 of about 8,155 (173)

Cell Death and Unprecedent Cytoskeletal Changes in <i>Leishmania amazonensis</i> Parasites Evidenced by 3D Reconstruction. [PDF]

Chem Biomed Imaging
Machado RRB, Bakoshi ABK, Ueda-Nakamura T, Lautenschlager SOS, Sarragiotto MH, Lazarin-Bidóia D, Nakamura CV.   +6 more
europepmc   +1 more source

Public health round-up. [PDF]

Bull World Health Organ
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis

International Journal of Antimicrobial Agents, 2022
Jos Beijnen, Thomas P C Dorlo
exaly  

The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice

British Journal of Pharmacology, 2021
Eva Knuplez, Athina Trakaki, Gunther Marsche   +2 more
exaly  

Mechanisms of experimental resistance of to miltefosine: Implications for clinical use

Drug Resistance Updates, 2006
Santiago Castanys, Simon L Croft
exaly  

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of and persists in vivo

International Journal of Antimicrobial Agents, 2007
Santiago Castanys, Simon L Croft, Karin Seifert   +2 more
exaly  

Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species

FEBS Journal, 2013
Prakash Saudagar, Vikash Kumar Dubey
exaly  

Characterisation of promastigotes resistant to hexadecylphosphocholine (miltefosine)

International Journal of Antimicrobial Agents, 2003
Santiago Castanys, Simon L Croft, Karin Seifert   +2 more
exaly  

Miltefosine resistance in involves suppression of oxidative stress-induced programmed cell death

Experimental Parasitology, 2013

exaly